Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.
作者信息
Boyarsky Brian J, Ou Michael T, Greenberg Ross S, Teles Aura T, Werbel William A, Avery Robin K, Massie Allan B, Segev Dorry L, Garonzik-Wang Jacqueline M
机构信息
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD.
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
出版信息
Transplantation. 2021 May 1;105(5):e56-e57. doi: 10.1097/TP.0000000000003654.
Abstract
摘要
相似文献
1
Safety of the First Dose of SARS-CoV-2 Vaccination in Solid Organ Transplant Recipients.实体器官移植受者中首剂严重急性呼吸综合征冠状病毒2疫苗接种的安全性
Transplantation. 2021 May 1;105(5):e56-e57. doi: 10.1097/TP.0000000000003654.
2
Assessment of 4 Doses of SARS-CoV-2 Messenger RNA-Based Vaccine in Recipients of a Solid Organ Transplant.评估 4 剂 SARS-CoV-2 信使 RNA 疫苗在实体器官移植受者中的效果。
JAMA Netw Open. 2021 Nov 1;4(11):e2136030. doi: 10.1001/jamanetworkopen.2021.36030.
3
Antibody Response to an mRNA SARS-CoV-2 Vaccine Following Initial Vaccination With Ad.26.COV2.S in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者初次接种Ad.26.COV2.S后对mRNA SARS-CoV-2疫苗的抗体反应：病例系列
Transplantation. 2022 Feb 1;106(2):e161-e162. doi: 10.1097/TP.0000000000003991.
4
Safety and Immunogenicity of Anti-SARS-CoV-2 Messenger RNA Vaccines in Recipients of Solid Organ Transplants.实体器官移植受者中抗SARS-CoV-2信使核糖核酸疫苗的安全性和免疫原性
Ann Intern Med. 2021 Sep;174(9):1336-1338. doi: 10.7326/M21-1341. Epub 2021 May 25.
5
Safety and Immunogenicity of a Third Dose of SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients: A Case Series.实体器官移植受者接种第三剂新冠病毒疫苗的安全性和免疫原性：病例系列
Ann Intern Med. 2021 Sep;174(9):1330-1332. doi: 10.7326/L21-0282. Epub 2021 Jun 15.
6
Effectiveness of COVID-19 Vaccines Against Hospitalization and Death With the SARS-CoV-2 Delta Variant in Solid Organ and Islet Transplant Recipients.新冠病毒疫苗对实体器官和胰岛移植受者中因感染严重急性呼吸综合征冠状病毒2（SARS-CoV-2）德尔塔变异株导致的住院和死亡的有效性。
Transplantation. 2022 Jun 1;106(6):e310-e311. doi: 10.1097/TP.0000000000004104. Epub 2022 Mar 8.
7
Adverse events after SARS-CoV-2 vaccination in solid organ transplant recipients: A systematic review.实体器官移植受者接种新型冠状病毒2疫苗后的不良事件：一项系统评价。
Transpl Infect Dis. 2022 Dec;24(6):e13936. doi: 10.1111/tid.13936. Epub 2022 Sep 6.
8
Immunogenicity of a Single Dose of SARS-CoV-2 Messenger RNA Vaccine in Solid Organ Transplant Recipients.mRNA 疫苗在实体器官移植受者中的单剂免疫原性。
JAMA. 2021 May 4;325(17):1784-1786. doi: 10.1001/jama.2021.4385.
9
Poor Humoral Response in Solid Organ Transplant Recipients Following Complete mRNA SARS-CoV-2 Vaccination.实体器官移植受者完成mRNA SARS-CoV-2疫苗接种后体液免疫反应不佳。
Clin Chem. 2021 Dec 30;68(1):251-253. doi: 10.1093/clinchem/hvab149.
10
Seroconversions After Withdrawal From Mycophenolate Mofetil in Solid Organ Transplant Recipients Without a Third Dose of BNT162b2 mRNA Coronavirus Disease 2019 Vaccine: A Case Series.实体器官移植受者停用吗替麦考酚酯后在未接种第三剂BNT162b2 mRNA新型冠状病毒肺炎疫苗情况下的血清学转换：病例系列
Transplantation. 2022 Apr 1;106(4):e238-e239. doi: 10.1097/TP.0000000000004043.
引用本文的文献
1
Vaccination Coverage for Medically Indicated Vaccines in a Convenience Sample of Severely Immunocompromised Patients with COVID-19: An Observational Cohort Study.新冠病毒病严重免疫功能低下患者便利样本中医疗必需疫苗的接种覆盖率：一项观察性队列研究
Vaccines (Basel). 2024 Dec 9;12(12):1383. doi: 10.3390/vaccines12121383.
2
Comprehensive Review of COVID-19: Epidemiology, Pathogenesis, Advancement in Diagnostic and Detection Techniques, and Post-Pandemic Treatment Strategies.新型冠状病毒肺炎（COVID-19）的全面综述：流行病学、发病机制、诊断和检测技术的进展，以及大流行后的治疗策略。
Int J Mol Sci. 2024 Jul 26;25(15):8155. doi: 10.3390/ijms25158155.
3
The Long-Term Immunogenicity of mRNABNT162b Third Vaccine Dose in Solid Organ Transplant Recipients.mRNA BNT162b第三剂疫苗在实体器官移植受者中的长期免疫原性
Vaccines (Basel). 2024 Feb 22;12(3):224. doi: 10.3390/vaccines12030224.
4
Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.实体器官移植受者对 SARS-CoV-2 感染的易感性和对 COVID-19 疫苗接种的免疫反应。
J Infect Dis. 2023 Aug 4;228(Suppl 1):S34-S45. doi: 10.1093/infdis/jiad152.
5
Understanding Concerns about COVID-19 and Vaccination: Perspectives from Kidney Transplant Recipients.了解肾移植受者对新冠病毒病及疫苗接种的担忧：观点剖析
Vaccines (Basel). 2023 Jun 22;11(7):1134. doi: 10.3390/vaccines11071134.
6
COVID-19 vaccine acceptance among kidney transplant recipients in Singapore.新加坡肾移植受者对新冠病毒疫苗的接受情况。
Singapore Med J. 2025 Feb 1;66(2):73-80. doi: 10.4103/singaporemedj.SMJ-2021-332. Epub 2023 Apr 26.
7
Investigation on the hesitancy of COVID-19 vaccination among liver transplant recipients: A cross-sectional study in China.中国一项关于肝移植受者对 COVID-19 疫苗犹豫的横断面研究。
Front Public Health. 2022 Dec 15;10:1014942. doi: 10.3389/fpubh.2022.1014942. eCollection 2022.
8
COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data.接种疫苗与未接种疫苗的肝移植和肾移植受者的COVID-19死亡率：一项基于美国单中心历史数据的倾向评分匹配研究。
Vaccines (Basel). 2022 Nov 13;10(11):1921. doi: 10.3390/vaccines10111921.
9
COVID-19 Vaccination in Kidney Transplant Candidates and Recipients.肾移植候选者和接受者中的新冠病毒疫苗接种
Vaccines (Basel). 2022 Oct 27;10(11):1808. doi: 10.3390/vaccines10111808.
10
New-onset and relapsed liver diseases following COVID-19 vaccination: a systematic review.新型冠状病毒肺炎疫苗接种后新发和复发肝病：系统评价。
BMC Gastroenterol. 2022 Oct 13;22(1):433. doi: 10.1186/s12876-022-02507-3.
Zotero 插件